Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-04-23 @ 8:44 AM
Study NCT ID:
NCT04808505
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2021-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
Sponsor:
Amicus Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ATB200-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None